ACXP CIK: 1736243

Acurx Pharmaceuticals, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−5.01
FY22:
−7.54
FY23:
−9.80
FY24:
−10.4
FY25:
−6.79
Change from FY21 to FY25
millions USD
FY21:
14.8
FY22:
3.70
FY23:
8.16
FY24:
6.62
FY25:
10.6
millions USD
FY21:
9.78
FY22:
−3.85
FY23:
−1.64
FY24:
−3.77
FY25:
3.85

All amounts in millions USD Data source:SEC EDGAR